61 min listen
Dr. Monika Gulia-Nuss: Biotech and Tick Vectored Disease
Dr. Monika Gulia-Nuss: Biotech and Tick Vectored Disease
ratings:
Length:
32 minutes
Released:
Feb 26, 2022
Format:
Podcast episode
Description
Ticks are significant disease vectors, with an emerging scope of pathologies associated with tick bites. New technologies have accelerated the ability to genetically engineer ticks, creating new opportunities to understand gene function in ticks, as well as potentially use gene editing to control numbers or affect disease vectoring. Dr. Monika Gulia-Nuss (University of Nevada, Reno) and Dr. Jason Rasgon (Penn State University) describe tick disease transmission, new transformation technology, and potential applications.
Released:
Feb 26, 2022
Format:
Podcast episode
Titles in the series (100)
The SciBabe Talks Toxins; Your Questions Answered: Today chemophobia rules supreme. From fast-food establishments to farming critics, everyone seems to be an expert, except the experts! Talking Biotech #19 features The SciBabe, Yvette d’Entremont (@TheSciBabe). She has experience in the chemical indust by Talking Biotech with Dr. Kevin Folta